CONTRAVIR PHARMACEUTICALS INC Chart calendar ContraVir Pharmaceuticals Inc
bc5a8ca327d6660bea4ec4131c7d7.XNju-lbvGAHo-6GfrfUHzKryCQfB3ZTNgkmk87evxwI.MpeWrweJcEPfsMj8zINlofmAbWqquOWgsDjToP34iFAWu6XIHdtoVqG5yg~685f5dd5c832e04fa0041052c26e5456
Upcoming events on ContraVir Pharmaceuticals Inc
No events available
Past events on ContraVir Pharmaceuticals Inc
| 2024-01-05 | NASH-TAG Conference |
| 2023-11-29 11:00 | Obesity & NASH Drug Development Summit |
| 2023-11-13 16:30 | American Association for the Study of Liver Diseases Conference |
| 2023-09-27 09:45 | Cantor Global Healthcare Conference |
| 2023-06-22 09:00 | Annual General Meeting |
| 2023-06-21 03:00 | European Association for the Study of the Liver International Liver Congress - Abstract No 2552 |
| 2023-06-21 03:00 | European Association for the Study of the Liver International Liver Congress - Abstract No 1893 |
| 2023-05-26 09:00 | Canadian Society for Pharmaceutical Sciences Symposium |
| 2023-05-22 08:30 | Business Update Call |
| 2023-04-18 09:00 | American Association for Cancer Research Meeting |
| 2023-03-02 | Global NASH Congress |
| 2023-01-07 11:40 | NASH-TAG Conference |
| 2022-12-14 | Extraordinary Shareholders Meeting |
| 2022-11-09 15:00 | Antifibrotic Drug Development Summit |
| 2022-11-05 13:00 | American Association for the Study of Liver Diseases Meeting - Poster Number 2553 |
| 2022-11-05 13:00 | American Association for the Study of Liver Diseases Meeting - Poster Number 2527 |
| 2022-10-26 13:30 | ThinkEquity Conference |
| 2022-09-28 09:00 | Cantor Oncology, Hematology & HemeOnc Conference - Panel |
| 2022-09-20 05:45 | International Society for Biomedical Research on Alcoholism and European Society for Biomedical Rese |
| 2022-09-11 | H.C. Wainwright Global Investment Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | -20,1 -17,2 -16.67% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -7,77 -7,53 -3.14% | -20,1 -21,0 4.19% | -30,4 -30,5 0.39% | -43,6 -45,5 4.2% | 0,00 -43,5 - | -51,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -7,95 -7,53 -5.47% | -20,3 -21,2 4.14% | -32,7 -32,5 -0.65% | -45,1 -45,6 1.19% | -49,3 -43,3 -13.98% | -51,6 |
|
Net income Million USD | Released Forecast Spread | -6,72 -7,53 10.82% | -20,4 -21,2 4.13% | -32,7 -32,5 -0.64% | -45,3 -46,2 1.9% | -48,9 -43,3 -13.04% | -51,6 |
|
EPS USD | Released Forecast Spread | -119 -23,8 -400% | -42,0 -33,9 -23.77% | -9,40 -8,80 -6.82% | -11,8 -12,1 2.75% | 0,00 -11,0 - | -11,4 |
| Announcement Date | 14/05/20 | 31/03/21 | 08/04/22 | 10/04/23 | 16/04/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - |
|
EBIT Million USD | Released Forecast Spread | -7,25 -9,70 25.23% | -20,0 -8,90 -124.7% | -8,47 -13,3 36.35% | -7,90 -9,82 19.55% | -13,2 -13,8 4.28% | -14,2 -12,7 -11.34% | -10,7 -12,0 11.28% | -11,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -6,93 -9,70 28.56% | -19,9 -8,90 -123.72% | -8,55 -13,3 35.73% | -9,70 -10,2 5.26% | -13,3 -13,8 3.91% | -14,1 -12,6 -11.87% | -10,5 -10,4 -1.3% | -11,5 -11,3 -1.48% |
|
Net income Million USD | Released Forecast Spread | -6,93 -9,70 28.56% | -19,9 -8,90 -123.72% | -8,55 -13,3 35.73% | -9,95 -10,8 8.08% | -13,3 -13,8 3.91% | -14,1 -12,6 -11.87% | -10,5 -10,4 -1.3% | -11,1 -11,3 2.14% |
|
EPS USD | Released Forecast Spread | -1,80 -2,60 30.77% | -5,20 -2,40 -116.67% | -2,20 -3,40 35.29% | -2,60 -2,70 3.7% | -3,48 -3,60 3.33% | -3,68 -3,28 -12.2% | -2,74 -3,12 12.18% | -2,63 |
| Announcement Date | 16/05/22 | 15/08/22 | 14/11/22 | 10/04/23 | 12/05/23 | 14/08/23 | 20/11/23 | 16/04/24 |
More events
Past sector events for ContraVir Pharmaceuticals Inc
| 2024-05-17 07:00 | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-05-16 07:46 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 01:00 | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-15 08:05 | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
| 2024-05-15 16:01 | CELCUITY INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:05 | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 16:00 | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 08:00 | IMMUNOME, INC.: Q1 2024 Earnings Release |
